METHOCARBAMOL

Posology The dose for adults is 1500 mg of methocarbamol 3 times daily. At the beginning of treatment, a dose of 1500 mg of methocarbamol 4 times a day is recommended. In severe cases, patients may take up to 7500 mg of methocarbamol per day.

Duration of use Methocarbamol 1500 mg film-coated Tablet should be taken as long as the symptoms of muscle spasm persist, but not longer than 30 days. Paediatric population The safety and efficacy of Methocarbamol 1500 mg film-coated Tablet in children and adolescents have not been established.

Method of administration Methocarbamol 1500 mg film-coated Tablet is for oral use. The film-coated tablets should be taken with plenty of water.

g. g. lips, tongue) or the extremities (hands, fingers, feet) Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Methocarbamol 1500 mg film-coated Tablet should be used with caution in patients with impaired renal function and/or impaired hepatic function. Interference with laboratory tests Methocarbamol may cause color interference in laboratory tests for hydroxyindoleacetic acid (5-HIAA) and vanillin mandelic acid (VMA).

Methocarbamol 1500 mg film-coated Tablet contains lactose. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicinal product. Methocarbamol 1500 mg film-coated Tablet contains sodium.

This medicine contains less than 1 mmol sodium (23 mg) per mg, that is to say essentially ‘sodium-free’.

1. • Comatose or precomatose states • Central nervous system (CNS) disorders • Myasthenia gravis • Patients with a tendency to epileptic convulsions